175 related articles for article (PubMed ID: 37095669)
1. Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer:
Murphy DJ; Mayoral M; Larici AR; Ginsberg MS; Cicchetti G; Fintelmann FJ; Marom EM; Truong MT; Gill RR
AJR Am J Roentgenol; 2023 Oct; 221(4):409-424. PubMed ID: 37095669
[TBL] [Abstract][Full Text] [Related]
2. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
3. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma.
Eradat J; Abtin F; Gutierrez A; Suh R
Cancer J; 2011; 17(1):38-48. PubMed ID: 21263266
[TBL] [Abstract][Full Text] [Related]
5. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
[TBL] [Abstract][Full Text] [Related]
6. Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Redman MW; Papadimitrakopoulou VA; Minichiello K; Hirsch FR; Mack PC; Schwartz LH; Vokes E; Ramalingam S; Leighl N; Bradley J; Miao J; Moon J; Highleyman L; Miwa C; LeBlanc ML; Malik S; Miller VA; Sigal EV; Adam S; Wholley D; Sigman C; Smolich B; Blanke CD; Kelly K; Gandara DR; Herbst RS
Lancet Oncol; 2020 Dec; 21(12):1589-1601. PubMed ID: 33125909
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: A retrospective study.
Cheng M; Fay M; Steinke K
Int J Hyperthermia; 2016 May; 32(3):316-23. PubMed ID: 26892261
[TBL] [Abstract][Full Text] [Related]
8. Image-guided ablative therapies for lung cancer.
Sharma A; Abtin F; Shepard JA
Radiol Clin North Am; 2012 Sep; 50(5):975-99. PubMed ID: 22974782
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
10. ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.
Rosenzweig KE; Chang JY; Chetty IJ; Decker RH; Ginsburg ME; Kestin LL; Kong FM; Lally BE; Langer CJ; Movsas B; Videtic GM; Willers H
J Am Coll Radiol; 2013 Sep; 10(9):654-64. PubMed ID: 23890874
[TBL] [Abstract][Full Text] [Related]
11. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.
Arbour KC; Riely GJ
JAMA; 2019 Aug; 322(8):764-774. PubMed ID: 31454018
[TBL] [Abstract][Full Text] [Related]
13. Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages.
Scagliotti G
Lung Cancer; 2002 Dec; 38 Suppl 3():S23-9. PubMed ID: 12468140
[TBL] [Abstract][Full Text] [Related]
14. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
Amini A; Correa AM; Komaki R; Chang JY; Tsao AS; Roth JA; Swisher SG; Rice DC; Vaporciyan AA; Lin SH
Ann Thorac Surg; 2012 Sep; 94(3):914-20. PubMed ID: 22819472
[TBL] [Abstract][Full Text] [Related]
15. Screening for patients with non-small cell lung cancer who could survive long term chemotherapy.
Wu XY; Huang XE
Asian Pac J Cancer Prev; 2015; 16(2):647-52. PubMed ID: 25684501
[TBL] [Abstract][Full Text] [Related]
16. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Morgensztern D; Campo MJ; Dahlberg SE; Doebele RC; Garon E; Gerber DE; Goldberg SB; Hammerman PS; Heist RS; Hensing T; Horn L; Ramalingam SS; Rudin CM; Salgia R; Sequist LV; Shaw AT; Simon GR; Somaiah N; Spigel DR; Wrangle J; Johnson D; Herbst RS; Bunn P; Govindan R
J Thorac Oncol; 2015 Jan; 10(1 Suppl 1):S1-63. PubMed ID: 25535693
[TBL] [Abstract][Full Text] [Related]
17. Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer.
Chaft JE; Rimner A; Weder W; Azzoli CG; Kris MG; Cascone T
Nat Rev Clin Oncol; 2021 Sep; 18(9):547-557. PubMed ID: 33911215
[TBL] [Abstract][Full Text] [Related]
18. Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment.
Colombi D; Di Lauro E; Silva M; Manna C; Rossi C; De Filippo M; Zompatori M; Ruffini L; Sverzellati N
Diagn Interv Radiol; 2013; 19(6):447-56. PubMed ID: 23996838
[TBL] [Abstract][Full Text] [Related]
19. Advances in systemic therapy for non-small cell lung cancer.
Miller M; Hanna N
BMJ; 2021 Nov; 375():n2363. PubMed ID: 34753715
[TBL] [Abstract][Full Text] [Related]
20. Post-chemotherapy and targeted therapy imaging of the chest in lung cancer.
Carter BW; Altan M; Shroff GS; Truong MT; Vlahos I
Clin Radiol; 2022 Jan; 77(1):e1-e10. PubMed ID: 34538577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
